SecProbe.io

Filing text and metadata
Intelligence Terminal Search Topics Monthly Activity About

Correspondence 0001193125-23-122153 from Taysha Gene Therapies, Inc. (TSHA) (CIK 0001806310) (TSHA)

Taysha Gene Therapies, Inc. (TSHA) (CIK 0001806310)
Date: April 27, 2023 · CIK: 0001806310 · Accession: 0001193125-23-122153

AI Filing Summary & Sentiment

File numbers found in text: 333-271144

Date
April 27, 2023
Author
Not clearly detected
Form
CORRESP
Company
Taysha Gene Therapies, Inc. (TSHA) (CIK 0001806310)

Letter

VIA EDGAR Division of Corporation Finance Request for Acceleration of Effective Date Acceleration Request Requested Date: Monday, May 1, Requested Time: 4:00 p.m. Eastern Time

Re: Taysha Gene Therapies, Inc.

Dear Mr. Gorsky:

In accordance with Rule 461 under the Securities Act of 1933, as amended, the undersigned registrant (the “Registrant”) hereby requests that the Securities and Exchange Commission take appropriate action to cause the above-referenced Registration Statement on Form S-3 (File No. 333-271144) (the “Registration Statement”) to become effective on Monday, May 1, 2023, at 4:00 p.m. Eastern Time, or as soon thereafter as is practicable.

Once the Registration Statement has been declared effective, please orally confirm that event with Madison Jones of Cooley LLP, counsel to the Registrant, at (202) 728-7087, or in her absence, Paul Alexander, at (202) 776-2118.

Very truly yours,
TAYSHA GENE THERAPIES, INC.

Show Raw Text
CORRESP
1
filename1.htm

CORRESP

 April 27, 2023

 VIA
EDGAR

 Joshua Gorsky

 U.S. Securities and Exchange Commission

 Division of Corporation Finance

 100 F Street, N.E.

Washington, D.C. 20549

 Re: Taysha Gene Therapies, Inc.

 Registration Statement on Form S-3 (File No. 333-271144)

 Request for Acceleration of Effective Date

Acceleration Request

 Requested Date: Monday, May 1,
2023

 Requested Time: 4:00 p.m. Eastern Time

Dear Mr. Gorsky:

 In accordance with Rule 461 under the
Securities Act of 1933, as amended, the undersigned registrant (the “Registrant”) hereby requests that the Securities and Exchange Commission take appropriate action to cause the above-referenced Registration Statement on
Form S-3 (File No. 333-271144) (the “Registration Statement”) to become effective on Monday, May 1, 2023, at 4:00 p.m. Eastern Time, or as
soon thereafter as is practicable.

 Once the Registration Statement has been declared effective, please orally confirm that event with Madison Jones of
Cooley LLP, counsel to the Registrant, at (202) 728-7087, or in her absence, Paul Alexander, at (202) 776-2118.

Very truly yours,

TAYSHA GENE THERAPIES, INC.

By:

 /s/ Sean P. Nolan

Sean P. Nolan

Chief Executive Officer